Consolidated Statements of Changes in Shareholders’ Equity - USD ($) $ in Thousands	Ordinary shares	Additional paid-in capital	Accumulated deficit	Total
Balance at Dec. 31, 2019	$ 92	$ 239,577	$ (186,091)	$ 53,578
Balance (in Shares) at Dec. 31, 2019	33,670,926
Loss			(61,573)	(61,573)
Issuance of Ordinary shares, net of issuance expenses of $10,902	$ 72	132,776		132,848
Issuance of Ordinary shares, net of issuance expenses of $10,902 (in Shares)	24,677,084
Exercise of options	$ 2	648		650
Exercise of options (in Shares)	652,143
Share-based compensation		3,368		3,368
Balance at Dec. 31, 2020	$ 166	376,369	(247,664)	128,871
Balance (in Shares) at Dec. 31, 2020	59,000,153
Loss			(89,793)	(89,793)
Grant of restricted shares	$ 2	(2)
Grant of restricted shares (in Shares)	531,477
Exercise of options	$ 1	625		626
Exercise of options (in Shares)	438,759
Share-based compensation		4,233		4,233
Balance at Dec. 31, 2021	$ 169	$ 381,225	$ (337,457)	$ 43,937
Balance (in Shares) at Dec. 31, 2021	59,970,389